21/04/2017 13:00:39

Evli Bank Plc renews its financial reporting

Related content
07 Dec - 
Evli Bank Plc's financial reporting in 2018
05 Dec - 
Evli Bank Plc: Conversion of 14,667 Evli's Series A sha..
05 Dec - 
Evli Bank Plc: Share subscriptions based on stock optio..

EVLI BANK PLC STOCK EXCHANGE RELEASE APRIL 21, 2017, AT 3.00 PM

Evli Bank Plc renews its financial reporting

Evli Bank Plc will alter its financial reporting as of the first quarter 2017. The alteration is due to the renewal of the organizational structure, announced on 24 January 2017. The purpose of the change is to enhance customer centricity even further and respond to the development trends of the business environment and the changing regulation.

As a consequence of the organizational change, Evli will have two business areas; Wealth Management and Investor Clients and Advisory and Corporate Clients. These are supported by the Group Operations, which include banking services, as well as Evli's own balance sheet investments. The result for the first quarter of 2017 will be reported in accordance with these business areas.

The first Interim report based on the new reporting structure for the period January-March 2017 will be published on 24 April 2017.

Comparison data of the new financial reporting for the year 2016 is presented below.

2016

SEGMENT INCOME STATEMENT, M€

Wealth Management & Investor Clients

1-12/ 2016

Advisory & Corporate Clients

1-12/ 2016

Group operations

1-12/ 2016

Unallocated

1-12/ 2016

Group

1-12/ 2016

REVENUE

         
Net interest 0.0 0.0 1.6 0.0 1.6
Net commissions 46.3 7.8 -0.1 0.3 54.3
Trading and FX result 0.8 0.0 2.8 0.4 4.0
Other operative income 0.0 0.0 0.1 0.0 0.1
External sales 47.2 7.9 4.3 0.7 60.0
Inter-segment sales -0.1 0.0 0.1 0.0 0.0

Total revenue

47.1

7.8

4.4

0.7

60.0

RESULT

 

 

 

 

 

Segment operating expenses -30.2 -6.0 -9.2 -0.4 -45.8

Business units operating profit before depreciations and Group allocations

16.9

1.9

-4.8

0.3

14.2

Depreciations -1.5 -0.6 -0.7 -0.4 -3.1

Business units operating profit before Group allocations

15.4

1.3

-5.5

-0.1

11.1

Allocated corporate expenses -8.5 0.0 8.5 0.0 0.0

Operating profit including Group allocations

6.9

1.3

3.1

-0.1

11.1

Share of profits (losses) of associates       1.1 1.1
Income taxes       -2.4 -2.4

Segment profit/loss after taxes

6.9

1.3

3.1

-1.5

9.7

EVLI BANK PLC

For additional information, please contact:

Juho Mikola, CFO, Evli Bank Plc, tel. +358 (0)9 4766 9871 or +358 (0)40 717 8888, juho.mikola@evli.com

Evli Bank Plc in brief

Evli Bank Plc is a Finnish private bank specializing in investment. Evli's clients are present and future high net worth private individuals, companies, and institutions including insurance companies, pension funds, organizations and municipal authorities. Evli offers asset management services, various services related to the capital markets, alternative investment products, investment research, advisory services related to mergers and acquisitions as well as administration of incentive programs. The company also offers a comprehensive selection of funds, and banking services that support clients' investment activities.

Distribution: Nasdaq Helsinki Ltd, main media, www.evli.com


This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Evli Pankki Oyj via Globenewswire

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

Dimensional Fund Advisors Ltd. : Form 8.3 - Tesco Plc - Ordinary shares

11/12/2017 10:25:28
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Dimensional Fund Advisors Ltd. ("Dimensional"), in its capacity ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Karyopharm Presents Positive Phase 1/2 Eltanexor Data at the American Society of Hematology 2017 Annual Meeting
2
Algeco Scotsman Announces Debt Package for Refinancing, Acquisition of Touax Solutions Modulaires SAS and Exercise of Put Option
3
Karyopharm Presents Positive Selinexor Data from the Phase 1b/2 STOMP Study at the American Society of Hematology 2017 Annual Meeting
4
Algeco Scotsman Announces Debt Package for Refinancing, Acquisition of Touax Solutions Modulaires SAS and Exercise of Put Option
5
ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at ASH Annual Meeting

Related stock quotes

Evli Pankki Oyj 9.23 0.9% Stock price increasing

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2017 21:00:27
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171124.1 - EUROWEB5 - 2017-12-11 22:00:27 - 2017-12-11 21:00:27 - 1000 - Website: OKAY